Register Login

Posts

Dabigatran Recommendation

On September 20, an FDA advisory panel unanimously recommended approval for Dabigatran (Pradaxa, Boehringer-Ingelheim) prophylaxis to prevent stroke in atrial fibrillation, as reported by Heartwire’s Steve Stiles. Dabigatran, an oral direct thrombin inhibitor, joins Rivaroxaban (Xarelto, Johnson & Johnson) an oral direct factor Xa inhibitor, as one of two new FDA panel-recommended oral antithrombotics that threaten to push […]
read more